Table 2.
Advantages and Limitations of Use of Various HCR Approaches
| Factor | One-Setting | CABG Followed by PCI | PCI Followed by CABG |
|---|---|---|---|
| LIMA-LAD patency | Assessment directly after completing anastomosis | Assessment during follow-up PCI | Not routinely assessed |
| Suitable in non-elective setting | No | No | Yes |
| PCI of complex lesions | Possible | Possible | Possible, but more risky with non-revascularized LAD |
| Arterial access for PCI | Obtain before anticoagulation administered for surgery | Obtain at the time of PCI | Obtain at the time of PCI |
| Anticoagulation | Administered once | Administered twice | Administered twice |
| Discontinue DAPT | No | No | Yes/No |
| Risk for intraoperative bleeding | High | Low | High (if DAPT continued) |
| Risk of acute stent thrombosis | Intermediate | Low | High |
| DES use | Suitable | Suitable | Not suitable |
| LOS | Likely to be shorter | Likely to be longera | Likely to be longera |
| Degree of coordination between teams | High degree of coordination | Lesser degree of coordination | Lesser degree of coordination |
| Costs | Hybrid room | Two procedures | Two procedures |
| Training of personnel | Reimbursement | Reimbursement | |
| Reimbursement |
The difference between LOS in 1-setting and staged settings depends primarily on the time interval between the 2 staged procedures.
CABG = coronary artery bypass graft; DAPT = dual antiplatelet therapy; DES = drug-eluting stent; LAD = left anterior descending artery; LIMA = left internal mammary artery; LOS = length-of-stay; PCI = percutaneous coronary intervention.